p300 suppresses leukemia development in NUP98-HOXD13 driven myelodysplastic syndrome
p300 suppresses leukemia development in NUP98-HOXD13 driven myelodysplastic syndrome |
|
https://doi.org/10.18632/oncotarget.23402
Na Man,
and Stephen D. Nimer
|
| 26603-26604 |
Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells
Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells |
|
https://doi.org/10.18632/oncotarget.24902
Yan Hu,
Xiaoou Li,
Yacong An,
Jinhong Duan,
and Xian-Da Yang
|
| 26605-26615 |
Association of genetic variants in ATR-CHEK1 and ATM-CHEK2 pathway genes with risk of colorectal cancer in a Chinese population
Association of genetic variants in ATR-CHEK1 and ATM-CHEK2 pathway genes with risk of colorectal cancer in a Chinese population |
|
https://doi.org/10.18632/oncotarget.24299
Shijia Wang,
Yue Zhang,
Min Chen,
Yong Wang,
Yifei Feng,
Ziwei Xu,
Dongsheng Zhang,
Yueming Sun,
and Zan Fu
|
| 26616-26624 |
Cryptotanshinone hinders renal fibrosis and epithelial transdifferentiation in obstructive nephropathy by inhibiting TGF-β1/Smad3/integrin β1 signal
Cryptotanshinone hinders renal fibrosis and epithelial transdifferentiation in obstructive nephropathy by inhibiting TGF-β1/Smad3/integrin β1 signal |
|
https://doi.org/10.18632/oncotarget.23803
Wei Wang,
Pang-Hu Zhou,
Wei Hu,
Chang-Geng Xu,
Xiang-Jun Zhou,
Chao-Zhao Liang,
and Jie Zhang
|
| 26625-26637 |
Anti-tumor roles of both strands of the miR-455 duplex: their targets SKA1 and SKA3 are involved in the pathogenesis of renal cell carcinoma
Anti-tumor roles of both strands of the miR-455 duplex: their targets SKA1 and SKA3 are involved in the pathogenesis of renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25410
Yasutaka Yamada,
Takayuki Arai,
Satoko Kojima,
Sho Sugawara,
Mayuko Kato,
Atsushi Okato,
Kazuto Yamazaki,
Yukio Naya,
Tomohiko Ichikawa,
and Naohiko Seki
|
| 26638-26658 |
CD73 expression and clinical significance in human metastatic melanoma
CD73 expression and clinical significance in human metastatic melanoma |
|
https://doi.org/10.18632/oncotarget.25426
Inês Monteiro,
Selena Vigano,
Mohamed Faouzi,
Isabelle Treilleux,
Olivier Michielin,
Christine Ménétrier-Caux,
Christophe Caux,
Pedro Romero,
and Laurence de Leval
|
| 26659-26669 |
Lymph node density in papillary thyroid carcinoma is a prognostic factor after adjusting for pathological stage
Lymph node density in papillary thyroid carcinoma is a prognostic factor after adjusting for pathological stage |
|
https://doi.org/10.18632/oncotarget.25453
Hidenori Suzuki,
Yusuke Koide,
Nobuhiro Hanai,
Daisuke Nishikawa,
Shintaro Beppu,
Shinji Mikami,
and Yasuhisa Hasegawa
|
| 26670-26678 |
An NFκB-dependent mechanism of tumor cell plasticity and lateral transmission of aggressive features
An NFκB-dependent mechanism of tumor cell plasticity and lateral transmission of aggressive features |
|
https://doi.org/10.18632/oncotarget.25465
Nancy Adriana Espinoza-Sánchez,
Jennifer Enciso,
Rosana Pelayo,
and Ezequiel M. Fuentes-Pananá
|
| 26679-26700 |
Overexpression of topoisomerase II alpha protein is a factor for poor prognosis in patients with luminal B breast cancer
Overexpression of topoisomerase II alpha protein is a factor for poor prognosis in patients with luminal B breast cancer |
|
https://doi.org/10.18632/oncotarget.25468
Hideo Shigematsu,
Shinji Ozaki,
Daisuke Yasui,
Hideki Yamamoto,
Junichi Zaitsu,
Daiki Taniyama,
Akihisa Saitou,
Kazuya Kuraoka,
Taizo Hirata,
and Kiyomi Taniyama
|
| 26701-26710 |
Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia
Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.25475
Jatinder K. Lamba,
Xueyuan Cao,
Susana C. Raimondi,
Roya Rafiee,
James R. Downing,
Lei Shi,
Tanja Gruber,
Raul C. Ribeiro,
Jeffrey E. Rubnitz,
and Stanley B. Pounds
|
| 26711-26723 |
Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis
Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis |
|
https://doi.org/10.18632/oncotarget.25477
Claire Calmettes,
Frederic Gabriel,
Elodie Blanchard,
Vincent Servant,
Stéphane Bouchet,
Nathanael Kabore,
Edouard Forcade,
Camille Leroyer,
Audrey Bidet,
Valérie Latrabe,
Thibaut Leguay,
Stephane Vigouroux,
Reza Tabrizi,
Dominique Breilh,
Isabelle Accoceberry,
Manuel Tunon de Lara,
Arnaud Pigneux,
Noel Milpied,
and Pierre-Yves Dumas
|
| 26724-26736 |
Klotho inhibits EGF-induced cell migration in Caki-1 cells through inactivation of EGFR and p38 MAPK signaling pathways
Klotho inhibits EGF-induced cell migration in Caki-1 cells through inactivation of EGFR and p38 MAPK signaling pathways |
|
https://doi.org/10.18632/oncotarget.25481
Mehdi Dehghani,
Reynolds K. Brobey,
Yue Wang,
Glauco Souza,
Robert J. Amato,
and Kevin P. Rosenblatt
|
| 26737-26750 |
miR-146a suppresses 5-lipoxygenase activating protein (FLAP) expression and Leukotriene B4 production in lung cancer cells
miR-146a suppresses 5-lipoxygenase activating protein (FLAP) expression and Leukotriene B4 production in lung cancer cells |
|
https://doi.org/10.18632/oncotarget.25482
Joseph R. Iacona,
Nicholas J. Monteleone,
and Carol S. Lutz
|
| 26751-26769 |
Long non-coding RNA RAB11B-AS1 prevents osteosarcoma development and progression via its natural antisense transcript RAB11B
Long non-coding RNA RAB11B-AS1 prevents osteosarcoma development and progression via its natural antisense transcript RAB11B |
|
https://doi.org/10.18632/oncotarget.24247
Zhixu Chen,
Zezheng Liu,
Yang Yang,
Zhaoyin Zhu,
Ridong Liang,
Bin Huang,
Di Wu,
Lei Yang,
Hai Lu,
Dadi Jin,
and Qingchu Li
|
| 26770-26786 |
The dynamics of HER2 status in esophageal adenocarcinoma
The dynamics of HER2 status in esophageal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.25507
Aafke Creemers,
Eva A. Ebbing,
Gerrit K.J. Hooijer,
Lisanne Stap,
Rajni A. Jibodh-Mulder,
Susanne S. Gisbertz,
Mark I. van Berge Henegouwen,
Maurits L. van Montfoort,
Maarten C.C.M. Hulshof,
Kausilia K. Krishnadath,
Martijn G.H. van Oijen,
Maarten F. Bijlsma,
Sybren L. Meijer,
and Hanneke W.M. van Laarhoven
|
| 26787-26799 |
Novel fluorinated carbonic anhydrase IX inhibitors reduce hypoxia-induced acidification and clonogenic survival of cancer cells
Novel fluorinated carbonic anhydrase IX inhibitors reduce hypoxia-induced acidification and clonogenic survival of cancer cells |
|
https://doi.org/10.18632/oncotarget.25508
Justina Kazokaitė,
Raymon Niemans,
Virginija Dudutienė,
Holger M. Becker,
Jānis Leitāns,
Asta Zubrienė,
Lina Baranauskienė,
Gabor Gondi,
Reinhard Zeidler,
Jurgita Matulienė,
Kaspars Tārs,
Ala Yaromina,
Philippe Lambin,
Ludwig J. Dubois,
and Daumantas Matulis
|
| 26800-26816 |
Nucleolin facilitates nuclear retention of an ultraconserved region containing TRA2β4 and accelerates colon cancer cell growth
Nucleolin facilitates nuclear retention of an ultraconserved region containing TRA2β4 and accelerates colon cancer cell growth |
|
https://doi.org/10.18632/oncotarget.25510
Yuzuru Satake,
Yuki Kuwano,
Tatsuya Nishikawa,
Kinuyo Fujita,
Saki Saijo,
Miki Itai,
Hiroki Tanaka,
Kensei Nishida,
and Kazuhito Rokutan
|
| 26817-26833 |
Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2
Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2 |
|
https://doi.org/10.18632/oncotarget.25515
Shinya Ishida,
Hiroki Akiyama,
Yoshihiro Umezawa,
Keigo Okada,
Ayako Nogami,
Gaku Oshikawa,
Toshikage Nagao,
and Osamu Miura
|
| 26834-26851 |
SMAD proteins directly suppress PAX2 transcription downstream of transforming growth factor-beta 1 (TGF-β1) signalling in renal cell carcinoma
SMAD proteins directly suppress PAX2 transcription downstream of transforming growth factor-beta 1 (TGF-β1) signalling in renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25516
Caiyun Grace Li,
Andrew Chantry,
Cherie Stayner,
Julia Horsfield,
and Michael R. Eccles
|
| 26852-26867 |
Metabolite profiling identifies a signature of tumorigenicity in hepatocellular carcinoma
Metabolite profiling identifies a signature of tumorigenicity in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.25525
Shamir Cassim,
Valérie-Ann Raymond,
Benoit Lacoste,
Pascal Lapierre,
and Marc Bilodeau
|
| 26868-26883 |
TNFAIP8 promotes prostate cancer cell survival by inducing autophagy
TNFAIP8 promotes prostate cancer cell survival by inducing autophagy |
|
https://doi.org/10.18632/oncotarget.25529
Suryakant Niture,
Malathi Ramalinga,
Habib Kedir,
Dorrelyn Patacsil,
Samiksha S. Niture,
James Li,
Haresh Mani,
Simeng Suy,
Sean Collins,
and Deepak Kumar
|
| 26884-26899 |
Liquid biopsy in pancreatic cancer: the beginning of a new era
Liquid biopsy in pancreatic cancer: the beginning of a new era |
|
https://doi.org/10.18632/oncotarget.24809
Dipesh Kumar Yadav,
Xueli Bai,
Rajesh Kumar Yadav,
Alina Singh,
Guogang Li,
Tao Ma,
Wei Chen,
and Tingbo Liang
|
| 26900-26933 |
Aptamers: novelty tools for cancer biology
Aptamers: novelty tools for cancer biology |
|
https://doi.org/10.18632/oncotarget.25260
Ricardo L. Pereira,
Isis C. Nascimento,
Ana P. Santos,
Isabella E.Y. Ogusuku,
Claudiana Lameu,
Günter Mayer,
and Henning Ulrich
|
| 26934-26953 |
Astroglial role in the pathophysiology of status epilepticus: an overview
Astroglial role in the pathophysiology of status epilepticus: an overview |
|
https://doi.org/10.18632/oncotarget.25485
Karina Vargas-Sánchez,
Maria Mogilevskaya,
John Rodríguez-Pérez,
María G. Rubiano,
José J. Javela,
and Rodrigo E. González-Reyes
|
| 26954-26976 |
Correction: Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting
Correction: Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting |
|
https://doi.org/10.18632/oncotarget.25604
Ji-Young Kim,
Ji-Hae Han,
Geon Park,
Young-Woo Seo,
Cheol-Won Yun,
Byung-Chul Lee,
Jeehyeon Bae,
Ae Ran Moon,
and Tae-Hyoung Kim
|
| 26977-26977 |
Correction: Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway
Correction: Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway |
|
https://doi.org/10.18632/oncotarget.25605
Mathieu Chocry,
Ludovic Leloup,
and Hervé Kovacic
|
| 26978-26979 |
